Abstract
Rheumatoid arthritis as a common autoimmune inflammatory disorder with unknown etiology can affect 0.5–1% of adults in developed countries. It involves more than just the patient’s joints and can be accompanied by several comorbidities and affect cardiovascular, pulmonary, and some other systems of the human body. Although cytokine-mediated pathways are mentioned to have a central role in RA pathogenesis, adaptive and innate immune systems and intracellular signaling pathways all have important roles in this process. Non-steroidal anti-inflammatory drugs, glucocorticoids, conventional disease-modifying anti-rheumatic drugs, and biological agents are some mentioned medications used for RA. They are accompanied by some adverse effects and treatment failures which elucidates the needing for novel and more powerful therapeutic approaches. Stem cell-based therapies and their beneficial effects on therapeutic processes of different diseases have been founded so far. They can be an alternative and promising therapeutic approach for RA, too; due to their effects on immune responses of the disease. This review, besides some explanations about RA characteristics, addresses the outcome of the stem cell-based therapies including mesenchymal stem cell transplantation and hematopoietic stem cell transplantation for RA and explains their effects on the disease improvement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACPA:
-
Anti–Citrullinated Protein Antibody
- Ad-MSCs:
-
Adipose-Derived Mesenchymal Stem Cells
- ADSCs:
-
Adipose-Derived Stem Cells
- AHSCT:
-
Autologous Hematopoietic Stem Cell Transplantation
- Allo-HSCT:
-
Allogeneic Hematopoietic Stem Cell Transplantation
- AP-1:
-
Activator Protein 1
- APTC:
-
Antiplatelet Trialists Collaboration
- BAFF:
-
B-cell Activating Factor
- BM:
-
Bone Marrow
- BM-MSCs:
-
Bone Marrow-MSCs
- CCR7:
-
CC-Chemokine Receptor type 7
- CD40L:
-
CD40 Ligand
- CFA:
-
Complete Freund’s Adjuvant
- CIA:
-
Collagen-Induced Arthritis
- COX:
-
Cyclooxygenase
- CXCR5:
-
Chemokine C-X-C Motif Receptor5
- CYC:
-
Cyclophosphamide
- DAS28:
-
Disease Activity Score 28
- DMARDs:
-
Disease-Modifying Anti-Rheumatic Drugs
- ESR:
-
Erythrocyte Sedimentation Rate
- FLSs:
-
Fibroblast-Like Synoviocytes
- Foxp3:
-
Forkhead box protein P3
- G-CSF:
-
Granulocyte-Colony Stimulating Factor
- GI:
-
Gastrointestinal
- GM-CSF:
-
Granulocyte-Macrophage Colony-Stimulating Factor
- GvHD:
-
Graft-versus-Host Disease
- hAdMSCs:
-
human Adipose-derived Mesenchymal Stem Cells
- haplo-SCT:
-
haplo-identical SCT
- HDC:
-
High-Dose Chemotherapy
- HLA:
-
Human Leukocyte Antigen
- HSCs:
-
Hematopoietic Stem Cells
- HSCT:
-
Hematopoietic Stem Cell Transplantation
- hUCMSCs:
-
Human UC-MSCs
- ICOS:
-
Inducible Costimulatory Molecule
- IFN:
-
Interferon
- IgG:
-
Immunoglobulin G
- IL:
-
Interleukin
- ILD:
-
Interstitial Lung Disease
- iNOS:
-
inducible Nitric Oxide Synthase
- JAK:
-
Janus Kinase
- JIA:
-
Juvenile Idiopathic Arthritis
- M-CSF:
-
Macrophage-Colony Stimulating Factor
- MHC:
-
Major Histocompatibility Complex
- MMPs:
-
Matrix Metalloproteinases
- MPCs:
-
Mesenchymal Precursor Cells
- MS:
-
Multiple Sclerosis
- MSCs:
-
Mesenchymal Stem Cells
- MSCT:
-
MSC Transplantation
- MTX:
-
Methotrexate
- NF-Κb:
-
Nuclear Factor Kappa B
- NK:
-
Natural Killer
- NLRs:
-
NOD-Like Receptors
- NOD:
-
Non-Obese Diabetic
- NOD:
-
Nucleotide-Binding Oligomerization Domain
- NSAIDs:
-
Nonsteroidal Anti-Inflammatory Drugs
- PBSCs:
-
peripheral blood stem cells
- PBSCT:
-
Peripheral Blood Stem Cell Transplantation
- PD-1:
-
Programmed Cell Death Protein 1
- PGE2:
-
Prostaglandin E2
- PI 3-kinase:
-
Phosphatidylinositol 3-Kinase
- PPI:
-
Proton Pump Inhibitor
- PTCL:
-
Peripheral T Cell Lymphoma
- RA:
-
Rheumatoid Arthritis
- RANKL:
-
Receptor Activator of Nuclear Factor κB Ligand
- RF:
-
Rheumatoid Factor
- rhTNFR:Fc:
-
recombinant human TNF Receptor:Fc Fusion Protein
- RORγt:
-
RAR-related Orphan Receptor Gamma
- SCT:
-
Stem Cell Transplantation
- SDF-1:
-
Stromal Cell-Derived Factor-1
- SLE:
-
Systemic Lupus Erythematosus
- SS:
-
Sjögren’s Syndrome
- T1D:
-
Type 1 Diabetes
- Tfh:
-
T Follicular helper
- TGFβ:
-
Transforming Growth Factor β
- Th:
-
T helper
- TLRs:
-
Toll-Like Receptors
- TNF:
-
Tumor Necrosis Factor
- Treg:
-
T regulatory cells
- UCB:
-
Umbilical Cord Blood
- UC-MSCs:
-
Umbilical Cord MSCs
- VAS:
-
Visual Analog Scale
References
Abasolo L, Tobías A, Leon L, Carmona L, Fernandez-Rueda JL, Rodriguez AB, Fernandez-Gutierrez B, Jover JA (2013) Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature. Reumatología Clínica (English Edition) 9(4):226–228
Abdelmawgoud H, Saleh A (2018) Anti-inflammatory and antioxidant effects of mesenchymal and hematopoietic stem cells in a rheumatoid arthritis rat model. Adv Clin Exp Med 27(7):873–880
Abughanam G, Elkashty OA, Liu Y, Bakkar MO, Tran SD (2019) Mesenchymal stem cells extract (MSCsE)-based therapy alleviates xerostomia and Keratoconjunctivitis sicca in Sjogren’s syndrome-like disease. Int J Mol Sci 20(19):4750
Aghayan HR, Soleimani M, Goodarzi P, Norouzi-Javidan A, Emami-Razavi SH, Larijani B, Arjmand B (2014) Magnetic resonance imaging of transplanted stem cell fate in stroke. J Res Med Sci 19(5):465–471
Aghayan HR, Payab M, Mohamadi-Jahani F, Aghayan SS, Larijani B, Arjmand B (2020) GMP-compliant production of human placenta-derived mesenchymal stem cells. In: Methods in molecular biology. Springer, New York
Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360–1372
Álvaro-Gracia JM, Jover JA, García-Vicuña R, Carreño L, Alonso A, Marsal S, Blanco F, Martínez-Taboada VM, Taylor P, Martín-Martín C (2017) Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann Rheum Dis 76(1):196–202
Arbeláez-Cortés Á, Bejarano-Pineda L, Toro-Gutiérrez CE (2013) Autologous peripheral hematopoietic stem cell transplantation. Autoimmunity: from Bench to Bedside [Internet]. El Rosario University Press
Arjmand B, Goodarzi P, Mohamadi-Jahani F, Falahzadeh K, Larijani B (2017) Personalized regenerative medicine. Acta Med Iran 55(3):144–149
Arjmand B, Goodarzi P, Aghayan HR, Payab M, Rahim F, Alavi-Moghadam S, Mohamadi-Jahani F, Larijani B (2019) Co-transplantation of human fetal mesenchymal and hematopoietic stem cells in type 1 diabetic mice model. Front Endocrinol (Lausanne) 10:761
Askari A, Moskowitz RW, Goldberg VM (1974) Subcutaneous rheumatoid nodules and serum rheumatoid factor without arthritis. JAMA 229(3):319–320
Atoui A, El Labban M, Ghaoui N, El Darsa H, El Cheikh J, Bazarbachi A (2019) Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma. Bone Marrow Transplant 55:979–981
Baharlou R, Ahmadi-Vasmehjani A, Faraji F, Atashzar MR, Khoubyari M, Ahi S, Erfanian S, Navabi S-S (2017) Human adipose tissue-derived mesenchymal stem cells in rheumatoid arthritis: regulatory effects on peripheral blood mononuclear cells activation. Int Immunopharmacol 47:59–69
Barker N (2014) Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 15(1):19–33
Bergot A-S, Giri R, Thomas R (2020) The microbiome and rheumatoid arthritis. Best Pract Res Clin Rheumatol:101497. https://doi.org/10.1016/j.berh.2020.101497
Berthelot J-M, Le Goff B, Maugars Y (2019) Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions? Arthritis Res Ther 21(1):239
Bickham K, Kivitz AJ, Mehta A, Frontera N, Shah S, Stryszak P, Popmihajlov Z, Peloso PM (2016) Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. BMC Musculoskelet Disord 17(1):331
Biehl JK, Russell B (2009) Introduction to stem cell therapy. J Cardiovasc Nurs 24(2):98
Brignier AC, Gewirtz AM (2010) Embryonic and adult stem cell therapy. J Allergy Clin Immunol 125(2):S336–S344
Burt RK, Georganas C, Schroeder J, Traynor A, Stefka J, Schuening F, Graziano F, Mineishi S, Brush M, Fishman M (1999a) Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 42(11):2281–2285
Burt RK, Traynor A, Burns W (1999b) Hematopoietic stem cell transplantation of multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. In: Advances in allogeneic hematopoietic stem cell transplantation. Springer, Boston, pp 157–184
Burt RK, Barr W, Oyama Y, Traynor A, Slavin S (2001) Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis. J Rheumatol Suppl 64:42–48
Caglayan S, Ahrens TD, Cieślar-Pobuda A, Staerk J (2019) Chapter 3 Modern ways of obtaining stem cells. In: Stem cells and biomaterials for regenerative medicine. Elsevier, pp 17–36
Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW (2002) Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347(26):2104–2110
Chen Y, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor R (2008) Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. NIHR Health Technology Assessment programme: Executive Summaries, NIHR Journals Library
Clark K, Zhang S, Barthe S, Kumar P, Pivetti C, Kreutzberg N, Reed C, Wang Y, Paxton Z, Farmer D (2019) Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis. Cell 8(12):1497
Crofford LJ (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15(3):S2
Cush JJ, Kavanaugh A, Weinblatt ME (2010) Rheumatoid arthritis: early diagnosis and treatment. Professional Communications, West Islip
De Bari C (2015) Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys? Arthritis Res Ther 17(1):113
de Oliveira PG, Farinon M, Sanchez-Lopez E, Miyamoto S, Guma M (2019) Fibroblast-like Synoviocytes glucose metabolism as a therapeutic target in rheumatoid arthritis. Front Immunol 10:1743
Edwards JC, Szczepański L, Szechiński J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T (2004) Efficacy of B-cell–targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581
El Qashty RMN, Mohamed NN, Radwan LRS, Ibrahim FMM (2018) Effect of bone marrow mesenchymal stem cells on healing of temporomandibular joints in rats with induced rheumatoid arthritis. Eur J Oral Sci 126(4):272–281
El-Jawhari J, El-Sherbiny Y, Jones E, McGonagle D (2014) Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. QJM Int J Med 107(7):505–514
Farquhar H, Vassallo R, Edwards AL, Matteson EL (2019) Pulmonary complications of rheumatoid arthritis. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers, New York, NY
Faustman DL, Davis M (2010) Stem cells in the spleen: therapeutic potential for Sjogren’s syndrome, type I diabetes, and other disorders. Int J Biochem Cell Biol 42(10):1576–1579
Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46(2):183–196
Gabriel SE (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 121(10):S9–S14
Ge F, Lin H, Li Z, Chang T (2019) Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci 40(3):479–487
Goodarzi P, Aghayan HR, Soleimani M, Norouzi-Javidan A, Mohamadi-Jahani F, Jahangiri S, Emami-Razavi SH, Larijani B, Arjmand B (2014) Stem cell therapy for treatment of epilepsy. Acta Med Iran 52(9):651–655
Goodarzi P, Aghayan HR, Larijani B, Soleimani M, Dehpour AR, Sahebjam M, Ghaderi F, Arjmand B (2015) Stem cell-based approach for the treatment of Parkinson’s disease. Med J Islam Repub Iran 29:168
Goodarzi P, Larijani B, Alavi-Moghadam S, Tayanloo-Beik A, Mohamadi-Jahani F, Ranjbaran N, Payab M, Falahzadeh K, Mousavi M, Arjmand B (2018) Mesenchymal stem cells-derived exosomes for wound regeneration. Adv Exp Med Biol 1119:119–131
Goodarzi P, Alavi-Moghadam S, Payab M, Larijani B, Rahim F, Gilany K, Bana N, Tayanloo-Beik A, Foroughi Heravani N, Hadavandkhani M, Arjmand B (2019a) Metabolomics analysis of mesenchymal stem cells. Int J Mol Cell Med 8(Suppl1):30–40
Goodarzi P, Falahzadeh K, Aghayan H, Payab M, Larijani B, Alavi-Moghadam S, Tayanloo-Beik A, Adibi H, Gilany K, Arjmand B (2019b) Therapeutic abortion and ectopic pregnancy: alternative sources for fetal stem cell research and therapy in Iran as an Islamic country. Cell Tissue Bank 20(1):11–24
Goodarzi P, Payab M, Alavi-Moghadam S, Larijani B, Rahim F, Bana N, Sarvari M, Adibi H, Foroughi Heravani N, Hadavandkhani M, Arjmand B (2019c) Development and validation of Alzheimer’s disease animal model for the purpose of regenerative medicine. Cell Tissue Bank 20(2):141–151
Gurusamy N, Alsayari A, Rajasingh S, Rajasingh J (2018) Adult stem cells for regenerative therapy. Prog Mol Biol Transl Sci (Elsevier) 160:1–22
Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Östör AJ (2011) Non-infectious pulmonary complications of newer biological agents for rheumatic diseases—a systematic literature review. Rheumatology 50(12):2297–2305
Harris HE, Tweedie F, White M, Samson K (2016) How to motivate patients with rheumatoid arthritis to quit smoking. J Rheumatol 43(4):691–698
Hatzimichael E, Tuthill M (2010) Hematopoietic stem cell transplantation. Stem Cells Cloning Adv Appl 3:105
Henriksson K, Jörgensen L, From J, Stratelis G (2013) FRI0539 Patient reported adherence to co-prescribed ppi gastro protection treatment in osteoarthritis, rheumatoid arthritis or ankylosing spondylitis patients using nsaid. Ann Rheum Dis 72(Suppl 3):A557–A557
Hirohata S, Yanagida T, Nakamura H, Yoshino S, Tomita T, Ochi T (2000) Bone marrow CD34+ progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals. Rheumatol Int 19(4):153–159
Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S i, Tomita T, Ochi T (2001) Induction of fibroblast-like cells from CD34+ progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol 70(3):413–421
Irwin MR, Olmstead R, Carrillo C, Sadeghi N, FitzGerald JD, Ranganath VK, Nicassio PM (2012) Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35(4):537–543
Johansson CB, Svensson M, Wallstedt L, Janson AM, Frisén J (1999) Neural stem cells in the adult human brain. Exp Cell Res 253(2):733–736
Jorgensen C, Noel D, Apparailly F, Sany J (2001) Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 60(4):305–309
Joseph R, Wang Y, Zhong L, Palecek SP, Nagy K, Agha-Mohammadi S (2020) Advances in induced pluripotent stem cell. In: Advances in induced pluripotent stem cell, p 185
Jung SY (2018) Adult stem cell treatment for rheumatoid arthritis. J Rheum Dis 25(3):158–168
Kafaja S, Segal K, Skerrett D, Itescu S, Furst D (2017) FRI0220 Allogeneic mesenchymal precursor cells (MPCS): a novel approach to treating biologic refractory rheumatoid arthritis. Ann Rheum Dis 76(Suppl 2):566–567
Källberg H, Ding B, Padyukov L, Bengtsson C, Rönnelid J, Klareskog L, Alfredsson L, E. S. Group (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70(3):508–511
Karamini A, Bakopoulou A, Andreadis D, Gkiouras K, Kritis A (2020) Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: a systematic review of in vivo studies. Stem Cell Rev 16:276–287
Kartiko BH, Siswanto FM, Purwata TE (2017) Mesenchymal stem cell (MSC) as a potential cell therapy for immune related disease. Bali Med J 6(1):38–43
Khaddour K, Mewawalla P (2019) Hematopoietic stem cell transplantation. StatPearls [internet]. StatPearls Publishing
Kiatpongsan S, Tannirandorn Y, Virutamasen P (2006) Introduction to stem cell medicine. J Med Assoc Thail 89(1):111
Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY (2007) Up-regulation of stromal cell–derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L–CD40 interaction. Arthritis Rheum 56(4):1076–1086
Kim J-H, Lee YT, Oh K, Cho J, Lee D-S, Hwang Y-i (2014) Paradoxical effects of human adipose tissue-derived mesenchymal stem cells on progression of experimental arthritis in SKG mice. Cell Immunol 292(1–2):94–101
Kragstrup TW, Andersen T, Heftdal LD, Hvid M, Gerwien J, Sivakumar P, Taylor PC, Senolt L, Deleuran B (2018) The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis. Front Immunol 9:2226
Lampropoulos C, Orfanos P, Bournia V, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis M, Tzioufas A, Moutsopoulos H, Vlachoyiannopoulos P (2015) Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. Clin Exp Rheumatol 33(2):216–224
Larijani B, NASLI EE, Amini P, Nikbin B, Alimoghaddam K, Amiri S, Malekzadeh R, Mojahed YN, Ghodsi M, Dowlati Y (2012) Stem cell therapy in treatment of different diseases. Acta Med Iran 50(2):79–96
Larijani B, Goodarzi P, Payab M, Alavi-Moghadam S, Rahim F, Bana N, Abedi M, Arabi M, Adibi H, Gilany K, Arjmand B (2019a) Metabolomics and cell therapy in diabetes mellitus. Int J Mol Cell Med 8(Suppl1):41–48
Larijani B, Goodarzi P, Payab M, Tayanloo-Beik A, Sarvari M, Gholami M, Gilany K, Nasli-Esfahani E, Yarahmadi M, Ghaderi F, Arjmand B (2019b) The design and application of an appropriate Parkinson’s disease animal model in regenerative medicine. Adv Exp Med Biol 50:79–96
Larijani B, Foroughi Heravani N, Alavi-Moghadam S, Goodarzi P, Rezaei-Tavirani M, Payab M, Gholami M, Razi F, Arjmand B (2020) Cell therapy targets for autism Spectrum disorders: hopes, challenges and future directions. Adv Exp Med Biol
Lazzerini PE, Capecchi PL, Laghi-Pasini F (2017) Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J 38(22):1717–1727
Lee YH, Seo YH (2018) SAT0167 Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials. Ann Rheum Dis 77(Suppl 2):944–944
Lee H-H, Song I-H, Friedrich M, Gauliard A, Detert J, Röwert J, Audring H, Kary S, Burmester G-R, Sterry W, Worm M (2007) Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists. Br J Dermatol 156(3):486–491
Leung PSC, Shuai Z, Liu B, Shu SA, Sun L (2017) Stem cell therapy in the treatment of rheumatic diseases and application in the treatment of systemic lupus erythematosus. In: Mina-Osorio P (ed) Next-generation therapies and technologies for immune-mediated inflammatory diseases. Springer International Publishing, Cham, pp 167–198
Lipsky PE, van der Heijde DM, Clair EWS, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343(22):1594–1602
Littlejohn EA, Monrad SU (2018) Early diagnosis and treatment of rheumatoid arthritis. Prim Care 45(2):237–255
Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z (2010) Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 12(6):R210
Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D, Feng X, Gao X, Shi S, Chen W, Sun L (2015) Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep 5(1):12777
Luque-Campos N, Contreras-López RA, Paredes-Martínez MJ, Torres MJ, Bahraoui S, Wei M, Espinoza F, Djouad F, Elizondo-Vega RJ, Luz-Crawford P (2019) Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Front Immunol 10:8459281
Ma X, Xu S (2013) TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep 1(2):177–184
Ma D, Xu K, Zhang G, Liu Y, Gao J, Tian M, Wei C, Li J, Zhang L (2019) Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol 74:105687
Matcham F, Ali S, Hotopf M, Chalder T (2015) Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev 39:16–29
Mattila K, Buttgereit F, Tuominen R (2014) Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis. Rheumatol Int 34(12):1751–1758
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219
McInnes IB, Buckley CD, Isaacs JD (2016) Cytokines in rheumatoid arthritis—shaping the immunological landscape. Nat Rev Rheumatol 12(1):63
Mellado M, Martínez-Muñoz L, Cascio G, Lucas P, Pablos JL, Rodríguez-Frade JM (2015) T cell migration in rheumatoid arthritis. Front Immunol 6:384
Mikkola HK, Orkin SH (2006) The journey of developing hematopoietic stem cells. Development 133(19):3733–3744
Moore J, Milliken S, David JB, Brooks P (2001) Peripheral blood stem cell transplantation for rheumatoid arthritis–Australian experience. J Rheumatol 64:8–12
Moore J, Snowden J, Pavletic S, Barr W, Burt R (2003) Hematopoietic stem cell transplantation for severe rheumatoid arthritis. Bone Marrow Transplant 32(1):S53–S56
Mor A, Abramson SB, Pillinger MH (2005) The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 115(2):118–128
Murrell W, Féron F, Wetzig A, Cameron N, Splatt K, Bellette B, Bianco J, Perry C, Lee G, Mackay-Sim A (2005) Multipotent stem cells from adult olfactory mucosa. Dev Dyn 233(2):496–515
Nikolov NP, Pavletic SZ (2008) Technology insight: hematopoietic stem cell transplantation for systemic rheumatic disease. Nat Clin Pract Rheumatol 4(4):184–191
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE (2016) Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 375:2519–2529
Noack M, Miossec P (2017) Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol 39(4):365–383
Noss EH, Brenner MB (2008) The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 223(1):252–270
O’Connor D (2017) Introduction to gene and stem-cell therapy. In: Molecular and cellular therapies for motor neuron diseases. Elsevier, San Diego, pp 141–165
O’Dell JR, Haire C, Erikson N, Drymalski W, Palmer W, Maloley P, Klassen LW, Wees S, Moore GF (1996) Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. J Rheumatol Suppl 44:72–74
O’Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS (2013) Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 369(4):307–318
Park EH, Lim H s, Lee S, Roh K, Seo KW, Kang KS, Shin K (2018) Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase Ia clinical trial. Stem Cells Transl Med 7(9):636–642
Payab M, Goodarzi P, Foroughi Heravani N, Hadavandkhani M, Zarei Z, Falahzadeh K, Larijani B, Rahim F, Arjmand B (2018) Stem cell and obesity: current state and future perspective. Adv Exp Med Biol 1089:1–22
Pedrosa M, Duarte C, Laranjeira P, Gomes J, Ribeiro T, Santos F, Antunes B, Pedreiro S, Henriques A, Martinho A, Fardilha M, Trindade H, da Silva J, Paiva A (2015) A1.10 Human bone marrow-derived mesenchymal stromal cells strongly inhibit cytokine production by naive, memory and effector CD4+ and CD8+ T cells from rheumatoid arthritis patients, independently of disease activity status. Ann Rheum Dis 74(Suppl 1):A4–A5
Pincus T, Castrejón I (2013) Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull NYU Hosp Jt Dis 71(suppl 1):S9
Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, Kang B-C, Lee YS, Nakama K, Piao M, Sohl B, Kurtz A (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 9(1):181
Rahim F, Arjmand B, Shirbandi K, Payab M, Larijani B (2018) Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. Stem Cell Investig 5:40
Scherer HU, Häupl T, Burmester GR (2020) The etiology of rheumatoid arthritis. J Autoimmun 110:102400
Schett G, Emery P, Tanaka Y, Burmester G, Pisetsky DS, Naredo E, Fautrel B, van Vollenhoven R (2016) Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Ann Rheum Dis 75(8):1428–1437
Silva JMF, Ladomenou F, Carpenter B, Chandra S, Sedlacek P, Formankova R, Grandage V, Friswell M, Cant AJ, Nademi Z (2018) Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Blood Adv 2(7):777–786
Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D, E. A. D. W. P. on behalf of the and P. Paediatric Diseases Working (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 47(6):770–790
Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6):1421–1432
Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Zhao C, Tang X, Yao G (2017) Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment. Clin Exp Rheumatol 35(2):288–295
Swann J (2011) Understanding rheumatoid arthritis: causes and treatment. Brit J Healthc Assist 5(1):15–17
Sykes M, Nikolic B (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435(7042):620–627
Tebib JG, Boughaba H, Letroublon MC, Bienvenu J, Noel E, Armanet P, Colson F, Roullet A, Bouvier M (1991) Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression. Eur Cytokine Netw 2(4):239–243
Tedeschi SK, Frits M, Cui J, Zhang ZZ, Mahmoud T, Iannaccone C, Lin TC, Yoshida K, Weinblatt ME, Shadick NA (2017) Diet and rheumatoid arthritis symptoms: survey results from a rheumatoid arthritis registry. Arthritis Care Res 69(12):1920–1925
Teng Y, Verburg R, Sont J, Van den Hout W, Breedveld F, Van Laar J (2005) Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 52(8):2272–2276
To K, Khan W (2019) Mesenchymal stem cell transplantation in rheumatoid arthritis. In: Stem cell transplantation for autoimmune diseases and inflammation. Springer, Cham, pp 63–74
Toes RE, Fibbe WE, Breedveld FC, van Laar JM (2002) High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Hum Immunol 63(8):627–637
Tuan RS, Boland G, Tuli R (2002) Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5(1):32
Ueyama H, Okano T, Orita K, Mamoto K, Sobajima S, Iwaguro H, Nakamura H (2020) Local transplantation of adipose-derived stem cells has a significant therapeutic effect in a mouse model of rheumatoid arthritis. Sci Rep 10(1):3076
Van Laar J, Tyndall A (2006) Adult stem cells in the treatment of autoimmune diseases. Rheumatology 45(10):1187–1193
Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RM, Bijlsma JW, van de Putte LB (2001) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 44(4):754–760
Vishwakarma A, Sharpe P, Shi S, Ramalingam M (2015) Chapter 1 An introduction to stem cell biology and tissue engineering. In: Stem cell biology and tissue engineering in dental sciences. Elsevier, pp 1–13
Walsh DA, McWilliams DF (2012) Pain in rheumatoid arthritis. Curr Pain Headache Rep 16(6):509–517
Wang Q, Li X-F, Ma L-H, Li J-X, Chen J-W, Li F, Xue L-J, Bai J (2011) Allogenic derived mesenchymal stem cells transplantation for 4 patients with rheumatoid arthritis [J]. Chin J Allergy Clin Immunol 3
Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H (2013) Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev 22(24):3192–3202
Wang W, Zhou H, Liu L (2018) Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem 158:502–516
Warrington KJ, Takemura S, Goronzy JJ, Weyand CM (2001) CD4+, CD28− T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 44(1):13–20
Weaver A (2004) The impact of new biologicals in the treatment of rheumatoid arthritis. Rheumatology 43(suppl_3):iii17–iii23
Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340(4):253–259
Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK (2003) Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48(1):35–45
Woodward WA, Chen MS, Behbod F, Rosen JM (2005) On mammary stem cells. J Cell Sci 118(16):3585–3594
Wulffraat NM, De Kleer IM, Prakken B (2006) Refractory juvenile idiopathic arthritis: using autologous stem cell transplantation as a treatment strategy. Expert Rev Mol Med 8(26):1–11
Xia Y, Yin R, Fu T, Zhang L, Zhang Q, Guo G, Li L, Gu Z (2016) Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis. Patient Prefer Adherence 10:735
Ye L, Li L, Wan B, Yang M, Hong J, Gu W, Wang W, Ning G (2017) Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Ther 8(1):90
Zeher M, Papp G, Nakken B, Szodoray P (2017) Hematopoietic stem cell transplantation in autoimmune disorders: from immune-regulatory processes to clinical implications. Autoimmun Rev 16(8):817–825
Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR, Adachi JD, Lems WF, Cooper C, Lane NE, I. O. F. C. I. on behalf of the and G. Bone Structure Working (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28(2):429–446
Zhao T, Zhang Z-N, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212–215
Zhou Y, Zhang X, Xue H, Liu L, Zhu J, Jin T (2019) Autologous mesenchymal stem cell transplantation in multiple sclerosis: a meta-analysis. Stem Cells Int 2019:8536785
Declarations
Funding: There is no financial support for this work.
Conflicts of interest/Competing interests: There is no Conflicts of/Competing interest.
Availability of data and material: Not Applicable.
Code availability: Not Applicable.
Authors’ contributions: Peyvand Parhizkar Roudsari wrote the first draft. Parisa Goodarzi , Akram Tayanloo-Beik, and Forough Azam Sayahpour helped to study and gather information, Mostafa Rezaei-Tavirani and Sepideh Alavi-Moghadam extensively edited the manuscript. Bagher Larijani participated in a critical review. Babak Arjmand helped supervise the project and gave final approval of the version to be published.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
Funding: We did not receive any funding from any institution.
Conflict of Interest: There is no conflict of interest.
Ethical Approval: This article does not contain any studies with animals and human participants performed by any of the authors.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Roudsari, P.P. et al. (2020). The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 12. Advances in Experimental Medicine and Biology(), vol 1326. Springer, Cham. https://doi.org/10.1007/5584_2020_581
Download citation
DOI: https://doi.org/10.1007/5584_2020_581
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71932-6
Online ISBN: 978-3-030-71933-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)